NCT05293574 is a Phase 4 clinical trial of norethisterone acetate in Ovarian Cyst Simple, sponsored by Assiut University.

Who is sponsoring NCT05293574?

NCT05293574 is sponsored by Assiut University.

What drugs are being tested in NCT05293574?

Interventions in NCT05293574: norethisterone acetate.

What condition does NCT05293574 study?

NCT05293574 studies Ovarian Cyst Simple.

Is NCT05293574 still recruiting?

NCT05293574 is currently status unknown. Last updated 24 March 2022.

Last reviewed 2022-03-24 · How we verify

NCT05293574

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Trial of Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts

Status unknown Phase 4 Last updated 24 March 2022

What this trial tests

Phase 4 trial testing norethisterone acetate in Ovarian Cyst Simple in 66 participants. Status unknown.

Timeline

1 October 2022

Primary endpoint
1 October 2023

1 December 2023

Quick facts

Lead sponsor	Assiut University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	66
Start date	1 October 2022
Primary completion	1 October 2023
Estimated completion	1 December 2023

Drugs / interventions tested

norethisterone acetate — full drug profile →

Conditions studied

Ovarian Cyst Simple — all drugs for Ovarian Cyst Simple →

Sponsor

Assiut University

Who can join

Adults 24 to 49, female only, with Ovarian Cyst Simple. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the effectiveness of (norethisterone acetate) in the treatment of spontaneously occurring simple ovarian cyst detected by ultrasonography compared with expectant management.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of norethisterone acetate

Trials testing the same drug.

NCT04290013 — Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature . · Phase 3 · unknown

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05293574 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 24 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05293574.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing